Who owns Indaptus Therapeutics Inc?
- Ticker: INDP
- CUSIP Number: 45339j204
Tip: Access positions for across all investors
Analyze quarterly positions in Indaptus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Indaptus Therapeutics stock
Who bought or sold Indaptus Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hrt Financial | 206k | $618k | 100% | Jun 2026 |
|
| Geode Capital Management | 57k | $169k | 109% | Jun 2026 |
|
| Jane Street | 54k | $161k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 34k | $101k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 14k | $42k | 100% | Jun 2026 |
|
| Millennium Management | 12k | $35k | 100% | Jun 2026 |
|
| Morgan Stanley | 2.7k | $4.9k | 100% | Mar 2026 |
|
| UBS Group | 478.00 | $1.4k | 100% | Jun 2026 |
|
| SBI Securities | 17.00 | $51.000000 | 0% | Jun 2026 |
|
| CWM | 2.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Indaptus Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Mar 2026 | 39k | $71k |
| Tower Research Capital | Mar 2026 | 1.9k | $3.4k |